Merck hopes to bolster its outlook this week by getting Gardasil and Januvia, the two new drugs most critical to the US drugmaker's turnround, past important milestones.
Gardasil, a vaccine for cervical cancer in women, is expected to get US regulatory approval by Thursday, while on Saturday, Merck will present key phase III data for Januvia, an oral diabetes drug, at a US diabetic medical conference.
Labels: No Prescription, Online Pharmacy, Prescription Drugs
# posted by Network @ 6:55 AM
